Skip to main content
Clinical Trials/NCT05592782
NCT05592782
Withdrawn
Not Applicable

Virtual Reality Mindfulness Study

University of California, Los Angeles0 sites60 target enrollmentOctober 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety
Sponsor
University of California, Los Angeles
Enrollment
60
Primary Endpoint
Pain severity
Status
Withdrawn
Last Updated
4 months ago

Overview

Brief Summary

This is an exploratory study investigating the use of virtual reality-based guided mindfulness meditation in improving pain, stress, and mood within various clinical populations. The feasibility of utilizing VR applications within the populations of patients with various specific disease types and clinical settings is a burgeoning area of research. The goal is to establish an association between the use of VR-based mindfulness meditation, and pain, stress, and mood scores.

Detailed Description

This is a two-center, multi-site exploratory study conducted within the University of California, Los Angeles Health and Greater Los Angeles VA systems. A total of 60 subjects will be recruited. Screening data will be reviewed to determine subject eligibility. Subjects who meet all inclusion criteria and none of the exclusion criteria will be entered into the study. Subjects will undergo assessments of stress, depression, anxiety, and pain at baseline, pre- and post-VR guided mediation, and monthly for three months. Each subject can undergo VR-guided meditation session no more than one time per day. In subjects who are hospitalized, an attempt will be made to have the subjects undergo the VR meditation and complete the pre- and post- meditation assessments daily until hospital discharge. Duration of the study is expected to be 1 year. Each session is expected to last approximately 15 minutes. Subjects will be given instructions on proper use of the VR devices and how to start the guided meditation software. Once familiar with the device, participants will undergo a guided VR meditation using a commercial VR application. The meditation will last approximately 15 minutes. Prior to starting and on upon completion of each VR meditation session, participants' state pain, anxiety, depression, and stress will be assessed. For each participant enrolled, baseline and monthly assessments using the DASS-21 and PPI-SFI3a will be performed for three consecutive months

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
October 1, 2023
Last Updated
4 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults at least 18 years old
  • Able to read and understand English (Guided meditation software has not yet been translated to languages other than English)

Exclusion Criteria

  • Age \<18 years old
  • Unable to speak, read or understand English language
  • Blindness or severe hearing impairment
  • Any disability or neurological deficit that would impair subject from using the virtual reality console
  • Significant movement disorder
  • Vertigo and/or motion sickness

Outcomes

Primary Outcomes

Pain severity

Time Frame: 2 hours

Change in VAS-100 scores pre- and post-use of VR meditation application

Completion of VR Mindfulness Meditation Session

Time Frame: 2 hours

Proportion of subjects able to complete VR meditation sessions

State Anxiety

Time Frame: 2 hours

Change in STAI-6 scores pre- and post-use of VR meditation application

Secondary Outcomes

  • Depression(2 hours)
  • Long term change in Pain severity(3 months)
  • Hospital Length of Stay(4 months)
  • Ease of use and acceptability(2 hours)
  • Stress(2 hours)
  • Long term change in Stress, Anxiety, and Depression(3 months)

Similar Trials